By Professor Jackie Hunter*
There
needs to be a fundamental shift in drug discovery and artificial Intelligence
holds the key to bringing the pharma industry into the 21st Century.
The
current drug discovery process needs to shift dramatically in order to meet the
needs both of society and patients in the 21st Century. Artificial
Intelligence and machine learning in particular, present the pharmaceutical industry
with a real opportunity to do R&D differently, so that it can operate more
efficiently and substantially improve success at the early stages of drug
development.
The
long term benefits of this will mean that the vast resources and money used to
develop drugs in the current process will be deployed more effectively to give
not only a better return on the investment but also a substantial increase in
the delivery of new medicines for serious diseases.
The current drug discovery process – too lengthy and very expensive
It
can take up to 15 years to translate a drug discovery idea from initial
inception to a market ready product. This contrasts with the rapidity of
innovation in other industry sectors.